May 3, 2019Open Access

Changes of serum IGF-1 and ET-1 levels in patients with osteoporosis and its clinical significance

Key Points

Key points are not available for this paper at this time.

Abstract

Patients with osteoporosis have decreased level of IGF-1 but increased level of ET-1, and they are closely related to cytokines and bone mineral density and may participate in the pathogenesis of osteoporosis.

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Cite This Study

Sun et al. (Fri,) studied this question.

synapsesocial.com/papers/69def5c692a5e9426ae93ef8 https://doi.org/https://doi.org/10.12669/pjms.35.3.84

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Association between polymorphisms in insulin-like growth factor-1 and risk of osteoporosis2015 · 13 citations
2IGF-1 Regulates Vertebral Bone Aging Through Sex-Specific and Time-Dependent Mechanisms2015 · 51 citations
3Bone metabolism in adolescent girls with eating disorders and weight loss: independent effects of weight change, insulin-like growth factor-1 and oestradiol2014 · 4 citations
4Interferon‐γ promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)‐1 and transforming growth factor (TGF) β22013 · 92 citations
5IGF-1 Gene Expression Is Differentially Regulated by Estrogen Receptors α and β in Mouse Endometrial Stromal Cells and Ovarian Granulosa Cells2014 · 34 citations

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper